name: | Lamotrigine |
ATC code: | N03AX09 | route: | oral |
n-compartments | 1 |
Lamotrigine is an anticonvulsant medication primarily used to treat epilepsy and bipolar disorder. It is approved for the prevention and control of seizures and for the maintenance treatment of bipolar I disorder. Lamotrigine stabilizes neuronal membranes by inhibiting voltage-sensitive sodium channels.
Pharmacokinetic parameters reported in healthy adult subjects, both male and female, following oral administration of lamotrigine.
Chan, V, et al., & Tett, SE (2001). Population pharmacokinetics of lamotrigine. Therapeutic drug monitoring 23(6) 630–635. DOI:10.1097/00007691-200112000-00006 PUBMED:https://pubmed.ncbi.nlm.nih.gov/11802095
Yang, H, et al., & Mei, S (2024). Population Pharmacokinetics of Lamotrigine and Its N2-Glucuronide Metabolite in Chinese Patients With Epilepsy. Therapeutic drug monitoring 46(5) 649–657. DOI:10.1097/FTD.0000000000001207 PUBMED:https://pubmed.ncbi.nlm.nih.gov/38666475
Jacob, S, & Nair, AB (2016). An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs. Drugs in R&D 16(4) 303–316. DOI:10.1007/s40268-016-0148-6 PUBMED:https://pubmed.ncbi.nlm.nih.gov/27766590